New combo pill for blood pressure and cholesterol gets first human test
NCT ID NCT06889012
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 31 times
Summary
This early-stage study tested a new drug called BR1018, along with two other drugs (BR1018A and BR1018B), in 60 healthy adults. The goal was to see how the drugs move through the body and to check for any safety issues. The study is now complete and helps researchers understand how to dose these medications for future trials in people with high blood pressure and high cholesterol.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Center, H PLUS Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.